We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
-0.91%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$117B
AUM Growth
-$6.8B
Cap. Flow
-$1.96B
Cap. Flow %
-1.67%
Top 10 Hldgs %
30.2%
Holding
4,248
New
63
Increased
1,950
Reduced
1,821
Closed
101

Top Sells

Rank Stock Value
1
IWV icon
iShares Russell 3000 ETF
IWV
+$607M
2
AAPL icon
Apple
AAPL
+$186M
3
MSFT icon
Microsoft
MSFT
+$139M
4
META icon
Meta Platforms (Facebook)
META
+$89.6M
5
NVDA icon
NVIDIA
NVDA
+$74.4M

Sector Composition

Rank Sector Weight
1 Technology 30.6%
2 Financials 12.67%
3 Consumer Discretionary 10.32%
4 Industrials 10.12%
5 Healthcare 9.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JKS
3351
JinkoSolar
JKS
$775M
$11.3K ﹤0.01%
444
-118
-21% -$3.12K
VALN
3352
Valneva
VALN
$488M
$11.2K ﹤0.01%
1,793
+30
+2% +$293
FLYX icon
3353
flyExclusive
FLYX
$60.1M
$11.2K ﹤0.01%
4,936
+1,563
+46% +$4.52K
EH
3354
EHang Holdings
EH
$372M
$11.1K ﹤0.01%
1,144
AMPY icon
3355
Amplify Energy
AMPY
$163M
$11.1K ﹤0.01%
1,776
SY
3356
So-Young International
SY
$194M
$10.9K ﹤0.01%
3,976
ARTNA icon
3357
Artesian Resources
ARTNA
$356M
$10.8K ﹤0.01%
340
KZIA
3358
Kazia Therapeutics
KZIA
$140M
$10.4K ﹤0.01%
1,402
-163
-10% -$1.14K
MRDN
3359
Meridian Holdings Inc
MRDN
$168M
$10.4K ﹤0.01%
1,436
+69
+5% +$555
TVRD
3360
Tvardi Therapeutics
TVRD
$23.5M
$10.3K ﹤0.01%
3,244
+118
+4% +$462
JMIA
3361
Jumia Technologies
JMIA
$726M
$10.3K ﹤0.01%
1,493
+103
+7% +$1.04K
IJK icon
3362
iShares S&P Mid-Cap 400 Growth ETF
IJK
$10.8B
$10.1K ﹤0.01%
+100
New +$10.3K
QNRX
3363
Quoin Pharmaceuticals
QNRX
$8.6M
$10K ﹤0.01%
1,521
-145
-9% -$1.31K
CVE icon
3364
Cenovus Energy
CVE
$54.6B
$10K ﹤0.01%
377
+32
+9% +$682
BNTX icon
3365
BioNTech
BNTX
$22.6B
$9.78K ﹤0.01%
110
HSAI
3366
Hesai Group
HSAI
$2.29B
$9.48K ﹤0.01%
496
+180
+57% +$4.54K
DQ
3367
Daqo New Energy
DQ
$790M
$9.21K ﹤0.01%
433
-140
-24% -$3.41K
WPP icon
3368
WPP
WPP
$4.04B
$9.05K ﹤0.01%
582
-382
-40% -$7.18K
PMI
3369
Picard Medical
PMI
$8.9K ﹤0.01%
8,564
+4,090
+91% +$5.93K
GDS icon
3370
GDS Holdings
GDS
$6.34B
$8.74K ﹤0.01%
217
+26
+14% +$1.11K
COE
3371
51Talk Online Education Group
COE
$96.6M
$8.68K ﹤0.01%
436
FFH
3372
DELISTED
FAIRFAX FINL HLDGS LTD SUB VTG
FFH
$8.51K ﹤0.01%
5
YSG
3373
Yatsen Holding
YSG
$311M
$8.38K ﹤0.01%
2,720
TIGR
3374
UP Fintech Holding
TIGR
$845M
$8.33K ﹤0.01%
1,323
DOYU
3375
DouYu International Holdings
DOYU
$136M
$8.18K ﹤0.01%
1,630

Similar funds

RhumbLine Advisers's Q1 2026 Portfolio in Review

As of Q1 2026, RhumbLine Advisers held 4,248 positions worth $117B, down 5.5% from $124B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Trading was light in Q1 2026: portfolio turnover was 3.9%. RhumbLine Advisers opened 63 new positions and exited 101, leaving the 4,248-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Financials and Consumer Discretionary.

  • RhumbLine Advisers's largest Q1 2026 buy was Versant Media Group: 361,319 shares worth $13.4M.
  • RhumbLine Advisers added most to Marsh in Q1 2026, an estimated $162M increase.
  • RhumbLine Advisers's biggest Q1 2026 reduction was iShares Russell 3000 ETF, cutting an estimated $607M.
  • RhumbLine Advisers fully exited Everpure Inc in Q1 2026, selling an estimated $58.7M.
  • RhumbLine Advisers's ten largest holdings make up 30% of its $117B portfolio in Q1 2026.
  • RhumbLine Advisers opened 63 new positions and closed 101 in Q1 2026.
  • RhumbLine Advisers's portfolio value fell 5.5% quarter-over-quarter to $117B.

Based on RhumbLine Advisers's 13F filing for Q1 2026, filed 12 May 2026.